Service & Software
Global Personalized Psychiatry Market Outlook, In‑Depth Analysis & Forecast to 2031
- Oct 04, 25
- ID: 533861
- Pages: 126
- Figures: 122
- Views: 1
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Personalized Psychiatry market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
COMPASS Pathways
Mindstrong Health
Pear Therapeutics
Cogito
Kaia Health
Sooma
GenoMind
Empatica
Akili Interactive
Neuroverse
Segment by Type
Depression and Anxiety
Bipolar Disorder
Addiction
Other
Segment by Application
Mental Health Professionals
Patients
Healthcare Providers
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Personalized Psychiatry study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Personalized Psychiatry market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
COMPASS Pathways
Mindstrong Health
Pear Therapeutics
Cogito
Kaia Health
Sooma
GenoMind
Empatica
Akili Interactive
Neuroverse
Segment by Type
Depression and Anxiety
Bipolar Disorder
Addiction
Other
Segment by Application
Mental Health Professionals
Patients
Healthcare Providers
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Personalized Psychiatry study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Personalized Psychiatry: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Personalized Psychiatry Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Depression and Anxiety
1.2.3 Bipolar Disorder
1.2.4 Addiction
1.2.5 Other
1.3 Market Segmentation by Application
1.3.1 Global Personalized Psychiatry Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Mental Health Professionals
1.3.3 Patients
1.3.4 Healthcare Providers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Personalized Psychiatry Revenue Estimates and Forecasts 2020-2031
2.2 Global Personalized Psychiatry Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Personalized Psychiatry Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Personalized Psychiatry Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Depression and Anxiety Market Size by Players
3.3.2 Bipolar Disorder Market Size by Players
3.3.3 Addiction Market Size by Players
3.3.4 Other Market Size by Players
3.4 Global Personalized Psychiatry Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Personalized Psychiatry Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Personalized Psychiatry Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Personalized Psychiatry Market Size by Type (2020-2031)
6.4 North America Personalized Psychiatry Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Personalized Psychiatry Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Personalized Psychiatry Market Size by Type (2020-2031)
7.4 Europe Personalized Psychiatry Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Personalized Psychiatry Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Personalized Psychiatry Market Size by Type (2020-2031)
8.4 Asia-Pacific Personalized Psychiatry Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Personalized Psychiatry Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Personalized Psychiatry Market Size by Type (2020-2031)
9.4 Central and South America Personalized Psychiatry Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Personalized Psychiatry Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Personalized Psychiatry Market Size by Type (2020-2031)
10.4 Middle East and Africa Personalized Psychiatry Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Personalized Psychiatry Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 COMPASS Pathways
11.1.1 COMPASS Pathways Corporation Information
11.1.2 COMPASS Pathways Business Overview
11.1.3 COMPASS Pathways Personalized Psychiatry Product Features and Attributes
11.1.4 COMPASS Pathways Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.1.5 COMPASS Pathways Personalized Psychiatry Revenue by Product in 2024
11.1.6 COMPASS Pathways Personalized Psychiatry Revenue by Application in 2024
11.1.7 COMPASS Pathways Personalized Psychiatry Revenue by Geographic Area in 2024
11.1.8 COMPASS Pathways Personalized Psychiatry SWOT Analysis
11.1.9 COMPASS Pathways Recent Developments
11.2 Mindstrong Health
11.2.1 Mindstrong Health Corporation Information
11.2.2 Mindstrong Health Business Overview
11.2.3 Mindstrong Health Personalized Psychiatry Product Features and Attributes
11.2.4 Mindstrong Health Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.2.5 Mindstrong Health Personalized Psychiatry Revenue by Product in 2024
11.2.6 Mindstrong Health Personalized Psychiatry Revenue by Application in 2024
11.2.7 Mindstrong Health Personalized Psychiatry Revenue by Geographic Area in 2024
11.2.8 Mindstrong Health Personalized Psychiatry SWOT Analysis
11.2.9 Mindstrong Health Recent Developments
11.3 Pear Therapeutics
11.3.1 Pear Therapeutics Corporation Information
11.3.2 Pear Therapeutics Business Overview
11.3.3 Pear Therapeutics Personalized Psychiatry Product Features and Attributes
11.3.4 Pear Therapeutics Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.3.5 Pear Therapeutics Personalized Psychiatry Revenue by Product in 2024
11.3.6 Pear Therapeutics Personalized Psychiatry Revenue by Application in 2024
11.3.7 Pear Therapeutics Personalized Psychiatry Revenue by Geographic Area in 2024
11.3.8 Pear Therapeutics Personalized Psychiatry SWOT Analysis
11.3.9 Pear Therapeutics Recent Developments
11.4 Cogito
11.4.1 Cogito Corporation Information
11.4.2 Cogito Business Overview
11.4.3 Cogito Personalized Psychiatry Product Features and Attributes
11.4.4 Cogito Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.4.5 Cogito Personalized Psychiatry Revenue by Product in 2024
11.4.6 Cogito Personalized Psychiatry Revenue by Application in 2024
11.4.7 Cogito Personalized Psychiatry Revenue by Geographic Area in 2024
11.4.8 Cogito Personalized Psychiatry SWOT Analysis
11.4.9 Cogito Recent Developments
11.5 Kaia Health
11.5.1 Kaia Health Corporation Information
11.5.2 Kaia Health Business Overview
11.5.3 Kaia Health Personalized Psychiatry Product Features and Attributes
11.5.4 Kaia Health Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.5.5 Kaia Health Personalized Psychiatry Revenue by Product in 2024
11.5.6 Kaia Health Personalized Psychiatry Revenue by Application in 2024
11.5.7 Kaia Health Personalized Psychiatry Revenue by Geographic Area in 2024
11.5.8 Kaia Health Personalized Psychiatry SWOT Analysis
11.5.9 Kaia Health Recent Developments
11.6 Sooma
11.6.1 Sooma Corporation Information
11.6.2 Sooma Business Overview
11.6.3 Sooma Personalized Psychiatry Product Features and Attributes
11.6.4 Sooma Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.6.5 Sooma Recent Developments
11.7 GenoMind
11.7.1 GenoMind Corporation Information
11.7.2 GenoMind Business Overview
11.7.3 GenoMind Personalized Psychiatry Product Features and Attributes
11.7.4 GenoMind Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.7.5 GenoMind Recent Developments
11.8 Empatica
11.8.1 Empatica Corporation Information
11.8.2 Empatica Business Overview
11.8.3 Empatica Personalized Psychiatry Product Features and Attributes
11.8.4 Empatica Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.8.5 Empatica Recent Developments
11.9 Akili Interactive
11.9.1 Akili Interactive Corporation Information
11.9.2 Akili Interactive Business Overview
11.9.3 Akili Interactive Personalized Psychiatry Product Features and Attributes
11.9.4 Akili Interactive Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.9.5 Akili Interactive Recent Developments
11.10 Neuroverse
11.10.1 Neuroverse Corporation Information
11.10.2 Neuroverse Business Overview
11.10.3 Neuroverse Personalized Psychiatry Product Features and Attributes
11.10.4 Neuroverse Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 Personalized PsychiatryIndustry Chain Analysis
12.1 Personalized Psychiatry Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Personalized Psychiatry Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Personalized Psychiatry Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Personalized Psychiatry: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Personalized Psychiatry Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Depression and Anxiety
1.2.3 Bipolar Disorder
1.2.4 Addiction
1.2.5 Other
1.3 Market Segmentation by Application
1.3.1 Global Personalized Psychiatry Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Mental Health Professionals
1.3.3 Patients
1.3.4 Healthcare Providers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Personalized Psychiatry Revenue Estimates and Forecasts 2020-2031
2.2 Global Personalized Psychiatry Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Personalized Psychiatry Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Personalized Psychiatry Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Depression and Anxiety Market Size by Players
3.3.2 Bipolar Disorder Market Size by Players
3.3.3 Addiction Market Size by Players
3.3.4 Other Market Size by Players
3.4 Global Personalized Psychiatry Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Personalized Psychiatry Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Personalized Psychiatry Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Personalized Psychiatry Market Size by Type (2020-2031)
6.4 North America Personalized Psychiatry Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Personalized Psychiatry Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Personalized Psychiatry Market Size by Type (2020-2031)
7.4 Europe Personalized Psychiatry Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Personalized Psychiatry Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Personalized Psychiatry Market Size by Type (2020-2031)
8.4 Asia-Pacific Personalized Psychiatry Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Personalized Psychiatry Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Personalized Psychiatry Market Size by Type (2020-2031)
9.4 Central and South America Personalized Psychiatry Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Personalized Psychiatry Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Personalized Psychiatry Market Size by Type (2020-2031)
10.4 Middle East and Africa Personalized Psychiatry Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Personalized Psychiatry Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 COMPASS Pathways
11.1.1 COMPASS Pathways Corporation Information
11.1.2 COMPASS Pathways Business Overview
11.1.3 COMPASS Pathways Personalized Psychiatry Product Features and Attributes
11.1.4 COMPASS Pathways Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.1.5 COMPASS Pathways Personalized Psychiatry Revenue by Product in 2024
11.1.6 COMPASS Pathways Personalized Psychiatry Revenue by Application in 2024
11.1.7 COMPASS Pathways Personalized Psychiatry Revenue by Geographic Area in 2024
11.1.8 COMPASS Pathways Personalized Psychiatry SWOT Analysis
11.1.9 COMPASS Pathways Recent Developments
11.2 Mindstrong Health
11.2.1 Mindstrong Health Corporation Information
11.2.2 Mindstrong Health Business Overview
11.2.3 Mindstrong Health Personalized Psychiatry Product Features and Attributes
11.2.4 Mindstrong Health Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.2.5 Mindstrong Health Personalized Psychiatry Revenue by Product in 2024
11.2.6 Mindstrong Health Personalized Psychiatry Revenue by Application in 2024
11.2.7 Mindstrong Health Personalized Psychiatry Revenue by Geographic Area in 2024
11.2.8 Mindstrong Health Personalized Psychiatry SWOT Analysis
11.2.9 Mindstrong Health Recent Developments
11.3 Pear Therapeutics
11.3.1 Pear Therapeutics Corporation Information
11.3.2 Pear Therapeutics Business Overview
11.3.3 Pear Therapeutics Personalized Psychiatry Product Features and Attributes
11.3.4 Pear Therapeutics Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.3.5 Pear Therapeutics Personalized Psychiatry Revenue by Product in 2024
11.3.6 Pear Therapeutics Personalized Psychiatry Revenue by Application in 2024
11.3.7 Pear Therapeutics Personalized Psychiatry Revenue by Geographic Area in 2024
11.3.8 Pear Therapeutics Personalized Psychiatry SWOT Analysis
11.3.9 Pear Therapeutics Recent Developments
11.4 Cogito
11.4.1 Cogito Corporation Information
11.4.2 Cogito Business Overview
11.4.3 Cogito Personalized Psychiatry Product Features and Attributes
11.4.4 Cogito Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.4.5 Cogito Personalized Psychiatry Revenue by Product in 2024
11.4.6 Cogito Personalized Psychiatry Revenue by Application in 2024
11.4.7 Cogito Personalized Psychiatry Revenue by Geographic Area in 2024
11.4.8 Cogito Personalized Psychiatry SWOT Analysis
11.4.9 Cogito Recent Developments
11.5 Kaia Health
11.5.1 Kaia Health Corporation Information
11.5.2 Kaia Health Business Overview
11.5.3 Kaia Health Personalized Psychiatry Product Features and Attributes
11.5.4 Kaia Health Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.5.5 Kaia Health Personalized Psychiatry Revenue by Product in 2024
11.5.6 Kaia Health Personalized Psychiatry Revenue by Application in 2024
11.5.7 Kaia Health Personalized Psychiatry Revenue by Geographic Area in 2024
11.5.8 Kaia Health Personalized Psychiatry SWOT Analysis
11.5.9 Kaia Health Recent Developments
11.6 Sooma
11.6.1 Sooma Corporation Information
11.6.2 Sooma Business Overview
11.6.3 Sooma Personalized Psychiatry Product Features and Attributes
11.6.4 Sooma Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.6.5 Sooma Recent Developments
11.7 GenoMind
11.7.1 GenoMind Corporation Information
11.7.2 GenoMind Business Overview
11.7.3 GenoMind Personalized Psychiatry Product Features and Attributes
11.7.4 GenoMind Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.7.5 GenoMind Recent Developments
11.8 Empatica
11.8.1 Empatica Corporation Information
11.8.2 Empatica Business Overview
11.8.3 Empatica Personalized Psychiatry Product Features and Attributes
11.8.4 Empatica Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.8.5 Empatica Recent Developments
11.9 Akili Interactive
11.9.1 Akili Interactive Corporation Information
11.9.2 Akili Interactive Business Overview
11.9.3 Akili Interactive Personalized Psychiatry Product Features and Attributes
11.9.4 Akili Interactive Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.9.5 Akili Interactive Recent Developments
11.10 Neuroverse
11.10.1 Neuroverse Corporation Information
11.10.2 Neuroverse Business Overview
11.10.3 Neuroverse Personalized Psychiatry Product Features and Attributes
11.10.4 Neuroverse Personalized Psychiatry Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 Personalized PsychiatryIndustry Chain Analysis
12.1 Personalized Psychiatry Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Personalized Psychiatry Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Personalized Psychiatry Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Personalized Psychiatry Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Personalized Psychiatry Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Personalized Psychiatry Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Personalized Psychiatry Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Personalized Psychiatry Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Personalized Psychiatry Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Personalized Psychiatry Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Personalized Psychiatry by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Psychiatry as of 2024)
Table 11. Global Personalized Psychiatry Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Personalized Psychiatry Companies Headquarters
Table 13. Global Personalized Psychiatry Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Personalized Psychiatry Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Personalized Psychiatry Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Personalized Psychiatry Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Personalized Psychiatry Revenue by Application (2026-2031) & (US$ Million)
Table 21. Personalized Psychiatry High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Personalized Psychiatry Growth Accelerators and Market Barriers
Table 25. North America Personalized Psychiatry Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Personalized Psychiatry Growth Accelerators and Market Barriers
Table 27. Europe Personalized Psychiatry Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Personalized Psychiatry Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Personalized Psychiatry Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Personalized Psychiatry Investment Opportunities and Key Challenges
Table 31. Central and South America Personalized Psychiatry Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Personalized Psychiatry Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Personalized Psychiatry Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. COMPASS Pathways Corporation Information
Table 35. COMPASS Pathways Description and Major Businesses
Table 36. COMPASS Pathways Product Features and Attributes
Table 37. COMPASS Pathways Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. COMPASS Pathways Revenue Proportion by Product in 2024
Table 39. COMPASS Pathways Revenue Proportion by Application in 2024
Table 40. COMPASS Pathways Revenue Proportion by Geographic Area in 2024
Table 41. COMPASS Pathways Personalized Psychiatry SWOT Analysis
Table 42. COMPASS Pathways Recent Developments
Table 43. Mindstrong Health Corporation Information
Table 44. Mindstrong Health Description and Major Businesses
Table 45. Mindstrong Health Product Features and Attributes
Table 46. Mindstrong Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Mindstrong Health Revenue Proportion by Product in 2024
Table 48. Mindstrong Health Revenue Proportion by Application in 2024
Table 49. Mindstrong Health Revenue Proportion by Geographic Area in 2024
Table 50. Mindstrong Health Personalized Psychiatry SWOT Analysis
Table 51. Mindstrong Health Recent Developments
Table 52. Pear Therapeutics Corporation Information
Table 53. Pear Therapeutics Description and Major Businesses
Table 54. Pear Therapeutics Product Features and Attributes
Table 55. Pear Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Pear Therapeutics Revenue Proportion by Product in 2024
Table 57. Pear Therapeutics Revenue Proportion by Application in 2024
Table 58. Pear Therapeutics Revenue Proportion by Geographic Area in 2024
Table 59. Pear Therapeutics Personalized Psychiatry SWOT Analysis
Table 60. Pear Therapeutics Recent Developments
Table 61. Cogito Corporation Information
Table 62. Cogito Description and Major Businesses
Table 63. Cogito Product Features and Attributes
Table 64. Cogito Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Cogito Revenue Proportion by Product in 2024
Table 66. Cogito Revenue Proportion by Application in 2024
Table 67. Cogito Revenue Proportion by Geographic Area in 2024
Table 68. Cogito Personalized Psychiatry SWOT Analysis
Table 69. Cogito Recent Developments
Table 70. Kaia Health Corporation Information
Table 71. Kaia Health Description and Major Businesses
Table 72. Kaia Health Product Features and Attributes
Table 73. Kaia Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Kaia Health Revenue Proportion by Product in 2024
Table 75. Kaia Health Revenue Proportion by Application in 2024
Table 76. Kaia Health Revenue Proportion by Geographic Area in 2024
Table 77. Kaia Health Personalized Psychiatry SWOT Analysis
Table 78. Kaia Health Recent Developments
Table 79. Sooma Corporation Information
Table 80. Sooma Description and Major Businesses
Table 81. Sooma Product Features and Attributes
Table 82. Sooma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Sooma Recent Developments
Table 84. GenoMind Corporation Information
Table 85. GenoMind Description and Major Businesses
Table 86. GenoMind Product Features and Attributes
Table 87. GenoMind Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. GenoMind Recent Developments
Table 89. Empatica Corporation Information
Table 90. Empatica Description and Major Businesses
Table 91. Empatica Product Features and Attributes
Table 92. Empatica Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Empatica Recent Developments
Table 94. Akili Interactive Corporation Information
Table 95. Akili Interactive Description and Major Businesses
Table 96. Akili Interactive Product Features and Attributes
Table 97. Akili Interactive Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Akili Interactive Recent Developments
Table 99. Neuroverse Corporation Information
Table 100. Neuroverse Description and Major Businesses
Table 101. Neuroverse Product Features and Attributes
Table 102. Neuroverse Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Neuroverse Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Personalized Psychiatry Product Picture
Figure 2. Global Personalized Psychiatry Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Depression and Anxiety Product Picture
Figure 4. Bipolar Disorder Product Picture
Figure 5. Addiction Product Picture
Figure 6. Other Product Picture
Figure 7. Global Personalized Psychiatry Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Mental Health Professionals
Figure 9. Patients
Figure 10. Healthcare Providers
Figure 11. Personalized Psychiatry Report Years Considered
Figure 12. Global Personalized Psychiatry Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 14. Global Personalized Psychiatry Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Personalized Psychiatry Revenue Market Share by Region (2020-2031)
Figure 16. Global Personalized Psychiatry Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Depression and Anxiety Revenue Market Share by Player in 2024
Figure 19. Bipolar Disorder Revenue Market Share by Player in 2024
Figure 20. Addiction Revenue Market Share by Player in 2024
Figure 21. Other Revenue Market Share by Player in 2024
Figure 22. Global Personalized Psychiatry Revenue Market Share by Type (2020-2031)
Figure 23. Global Personalized Psychiatry Revenue Market Share by Application (2020-2031)
Figure 24. North America Personalized Psychiatry Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players Personalized Psychiatry Revenue (US$ Million) in 2024
Figure 26. North America Personalized Psychiatry Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America Personalized Psychiatry Revenue (US$ Million) by Application (2020-2031)
Figure 28. US Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 29. Canada Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 31. Europe Personalized Psychiatry Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players Personalized Psychiatry Revenue (US$ Million) in 2024
Figure 33. Europe Personalized Psychiatry Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe Personalized Psychiatry Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 36. France Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 38. Italy Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 39. Russia Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Personalized Psychiatry Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players Personalized Psychiatry Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific Personalized Psychiatry Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific Personalized Psychiatry Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 45. Japan Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 47. Australia Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 48. India Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America Personalized Psychiatry Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players Personalized Psychiatry Revenue (US$ Million) in 2024
Figure 56. Central and South America Personalized Psychiatry Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America Personalized Psychiatry Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil Personalized Psychiatry Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina Personalized Psychiatry Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa Personalized Psychiatry Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players Personalized Psychiatry Revenue (US$ Million) in 2024
Figure 62. South America Personalized Psychiatry Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa Personalized Psychiatry Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries Personalized Psychiatry Revenue (2020-2025) & (US$ Million)
Figure 65. Israel Personalized Psychiatry Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt Personalized Psychiatry Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa Personalized Psychiatry Revenue (2020-2025) & (US$ Million)
Figure 68. Personalized Psychiatry Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Table 1. Global Personalized Psychiatry Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Personalized Psychiatry Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Personalized Psychiatry Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Personalized Psychiatry Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Personalized Psychiatry Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Personalized Psychiatry Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Personalized Psychiatry Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Personalized Psychiatry by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Psychiatry as of 2024)
Table 11. Global Personalized Psychiatry Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Personalized Psychiatry Companies Headquarters
Table 13. Global Personalized Psychiatry Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Personalized Psychiatry Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Personalized Psychiatry Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Personalized Psychiatry Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Personalized Psychiatry Revenue by Application (2026-2031) & (US$ Million)
Table 21. Personalized Psychiatry High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Personalized Psychiatry Growth Accelerators and Market Barriers
Table 25. North America Personalized Psychiatry Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Personalized Psychiatry Growth Accelerators and Market Barriers
Table 27. Europe Personalized Psychiatry Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Personalized Psychiatry Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Personalized Psychiatry Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Personalized Psychiatry Investment Opportunities and Key Challenges
Table 31. Central and South America Personalized Psychiatry Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Personalized Psychiatry Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Personalized Psychiatry Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. COMPASS Pathways Corporation Information
Table 35. COMPASS Pathways Description and Major Businesses
Table 36. COMPASS Pathways Product Features and Attributes
Table 37. COMPASS Pathways Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. COMPASS Pathways Revenue Proportion by Product in 2024
Table 39. COMPASS Pathways Revenue Proportion by Application in 2024
Table 40. COMPASS Pathways Revenue Proportion by Geographic Area in 2024
Table 41. COMPASS Pathways Personalized Psychiatry SWOT Analysis
Table 42. COMPASS Pathways Recent Developments
Table 43. Mindstrong Health Corporation Information
Table 44. Mindstrong Health Description and Major Businesses
Table 45. Mindstrong Health Product Features and Attributes
Table 46. Mindstrong Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Mindstrong Health Revenue Proportion by Product in 2024
Table 48. Mindstrong Health Revenue Proportion by Application in 2024
Table 49. Mindstrong Health Revenue Proportion by Geographic Area in 2024
Table 50. Mindstrong Health Personalized Psychiatry SWOT Analysis
Table 51. Mindstrong Health Recent Developments
Table 52. Pear Therapeutics Corporation Information
Table 53. Pear Therapeutics Description and Major Businesses
Table 54. Pear Therapeutics Product Features and Attributes
Table 55. Pear Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Pear Therapeutics Revenue Proportion by Product in 2024
Table 57. Pear Therapeutics Revenue Proportion by Application in 2024
Table 58. Pear Therapeutics Revenue Proportion by Geographic Area in 2024
Table 59. Pear Therapeutics Personalized Psychiatry SWOT Analysis
Table 60. Pear Therapeutics Recent Developments
Table 61. Cogito Corporation Information
Table 62. Cogito Description and Major Businesses
Table 63. Cogito Product Features and Attributes
Table 64. Cogito Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Cogito Revenue Proportion by Product in 2024
Table 66. Cogito Revenue Proportion by Application in 2024
Table 67. Cogito Revenue Proportion by Geographic Area in 2024
Table 68. Cogito Personalized Psychiatry SWOT Analysis
Table 69. Cogito Recent Developments
Table 70. Kaia Health Corporation Information
Table 71. Kaia Health Description and Major Businesses
Table 72. Kaia Health Product Features and Attributes
Table 73. Kaia Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Kaia Health Revenue Proportion by Product in 2024
Table 75. Kaia Health Revenue Proportion by Application in 2024
Table 76. Kaia Health Revenue Proportion by Geographic Area in 2024
Table 77. Kaia Health Personalized Psychiatry SWOT Analysis
Table 78. Kaia Health Recent Developments
Table 79. Sooma Corporation Information
Table 80. Sooma Description and Major Businesses
Table 81. Sooma Product Features and Attributes
Table 82. Sooma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Sooma Recent Developments
Table 84. GenoMind Corporation Information
Table 85. GenoMind Description and Major Businesses
Table 86. GenoMind Product Features and Attributes
Table 87. GenoMind Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. GenoMind Recent Developments
Table 89. Empatica Corporation Information
Table 90. Empatica Description and Major Businesses
Table 91. Empatica Product Features and Attributes
Table 92. Empatica Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Empatica Recent Developments
Table 94. Akili Interactive Corporation Information
Table 95. Akili Interactive Description and Major Businesses
Table 96. Akili Interactive Product Features and Attributes
Table 97. Akili Interactive Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Akili Interactive Recent Developments
Table 99. Neuroverse Corporation Information
Table 100. Neuroverse Description and Major Businesses
Table 101. Neuroverse Product Features and Attributes
Table 102. Neuroverse Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Neuroverse Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Personalized Psychiatry Product Picture
Figure 2. Global Personalized Psychiatry Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Depression and Anxiety Product Picture
Figure 4. Bipolar Disorder Product Picture
Figure 5. Addiction Product Picture
Figure 6. Other Product Picture
Figure 7. Global Personalized Psychiatry Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Mental Health Professionals
Figure 9. Patients
Figure 10. Healthcare Providers
Figure 11. Personalized Psychiatry Report Years Considered
Figure 12. Global Personalized Psychiatry Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 14. Global Personalized Psychiatry Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Personalized Psychiatry Revenue Market Share by Region (2020-2031)
Figure 16. Global Personalized Psychiatry Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Depression and Anxiety Revenue Market Share by Player in 2024
Figure 19. Bipolar Disorder Revenue Market Share by Player in 2024
Figure 20. Addiction Revenue Market Share by Player in 2024
Figure 21. Other Revenue Market Share by Player in 2024
Figure 22. Global Personalized Psychiatry Revenue Market Share by Type (2020-2031)
Figure 23. Global Personalized Psychiatry Revenue Market Share by Application (2020-2031)
Figure 24. North America Personalized Psychiatry Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players Personalized Psychiatry Revenue (US$ Million) in 2024
Figure 26. North America Personalized Psychiatry Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America Personalized Psychiatry Revenue (US$ Million) by Application (2020-2031)
Figure 28. US Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 29. Canada Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 31. Europe Personalized Psychiatry Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players Personalized Psychiatry Revenue (US$ Million) in 2024
Figure 33. Europe Personalized Psychiatry Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe Personalized Psychiatry Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 36. France Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 38. Italy Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 39. Russia Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Personalized Psychiatry Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players Personalized Psychiatry Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific Personalized Psychiatry Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific Personalized Psychiatry Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 45. Japan Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 47. Australia Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 48. India Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore Personalized Psychiatry Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America Personalized Psychiatry Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players Personalized Psychiatry Revenue (US$ Million) in 2024
Figure 56. Central and South America Personalized Psychiatry Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America Personalized Psychiatry Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil Personalized Psychiatry Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina Personalized Psychiatry Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa Personalized Psychiatry Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players Personalized Psychiatry Revenue (US$ Million) in 2024
Figure 62. South America Personalized Psychiatry Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa Personalized Psychiatry Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries Personalized Psychiatry Revenue (2020-2025) & (US$ Million)
Figure 65. Israel Personalized Psychiatry Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt Personalized Psychiatry Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa Personalized Psychiatry Revenue (2020-2025) & (US$ Million)
Figure 68. Personalized Psychiatry Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Spatial Metabolomics Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Global Pharmaceutical Process Analytical Technology (PAT) Software Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Global HASE Rheology Modifiers Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232